Status:
RECRUITING
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
Massachusetts General Hospital
Conditions:
HIV Infections
Adherence, Medication
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to al...
Detailed Description
African American men who have sex with men (AAMSM) have high HIV infection rates and disproportionate mortality. Critical to ending the HIV epidemic are efforts to reduce HIV transmission by optimizin...
Eligibility Criteria
Inclusion
- Participant inclusion criteria:
- AAMSM \>18 years with self-reported HIV infection;
- own a working cell phone;
- on ART for at least 6 months;
- have a case manager willing to participate in the study (for the clinical trial); and
- have suboptimal adherence - either have a detectable viral load in the past 6 months, self-reported \<90% adherence based on a 3-item measure or referral by their healthcare provider because of a recognized problem with ART adherence.
- For social support persons, participants will:
- report that they have a self-described meaningful relationship with the participant;
- be \>18 years of age;
- own a working cell phone and;
- be willing to provide support.
- For case managers, participants will have worked with clients with HIV at least 6 months prior to their participation in this study and own a working cell phone.
Exclusion
- Not meeting the inclusion criteria
- Not agreeing to informed consent concerning interactions with research team, data collection, and access to medical records.
- Candidates must provide consent to obtain a copy of their viral load results during the 12 months before and following study onset to confirm eligibility and explore long-term follow-up of possible effect.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06550804
Start Date
October 1 2024
End Date
July 1 2026
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois Chicago
Chicago, Illinois, United States, 60612